Association of Triglyceride/High Density Lipoprotein Cholesterol Ratio and Coronary Lesion Severity in Acute Myocardial Infarction Patients at Adam Malik Hospital, Medan
Abstract
Introduction: Coronary heart disease is the leading cause of worldwide death. A number of markers have been identified in terms of the atherogenic potential of the lipid profile.The TG/HDL-C ratio is an easy and economical non-invasive examination method as a predictor of coronary heart disease severity. The aim of this study is to assess the relationship of the TG/HDL ratio with the severity of coronary lesions.
Method: This cross-sectional study included 53 acute myocardial infarction patients undergoing coronary angiography. Exclusion criteria include (1)AMI patients receiving fibrinolytic therapy, (2) Patients who have routinely consumed lipid lowering drug for 6 weeks,(3) Incomplete coronary angiography and medical records. The TG/HDL ratio is the result of dividing the triglyceride value by HDL. The TG/HDL ratio was divided into 2 groups, namely the TG/HDL ratio <4 group and the TG/HDL ratio >4 group. The severity of coronary lesions was described by the SYNTAX score, which was divided into two: the low SYNTAX score group (≤22) and patients with a low SYNTAX score (≤22) and medium-high SYNTAX score (≥23). Bivariate analysis was performed to find the relationship between the TG/HDL ratio and the SYNTAX score. The value of p<0.05 was considered statistically significant.
Results: From 53 patients, 26 patients (49.1%) had a SYNTAX score ≥ 23 and 27 patients (50.9%) had a SYNTAX score < 23. Patients with NSTEMI, DM risk factors, and obesity were higher in the SYNTAX score group ≥23. From the results of statistical analysis, there was a significant relationship between the TG/HDL ratio with coronary lesion severity (p = 0,004).
Conclusion: Enhancement of TG/HDL ratio is correlated with coronary lesion severity in acute myocardial infarction patients using the SYNTAX score.
Downloads
Background :Coronary heart disease is the leading cause of worldwide death. A number of markers have been identified in terms of the atherogenic potential of the lipid profile.The TG/HDL-C ratio is an easy and economical non-invasive examination method as a predictor of coronary heart disease severity. The aim of this study is to assess the relationship of the TG/HDL ratio with the severity of coronary lesions.
Method: This cross-sectional study included 53 acute myocardial infarction patients undergoing coronary angiography. Exclusion criteria include (1)AMI patients receiving fibrinolytic therapy, (2) Patients who have routinely consumed lipid lowering drug for 6 weeks,(3) Incomplete coronary angiography and medical records. The TG/HDL ratio is the result of dividing the triglyceride value by HDL. The TG/HDL ratio was divided into 2 groups, namely the TG/HDL ratio <4 group and the TG/HDL ratio >4 group. The severity of coronary lesions was described by the SYNTAX score, which was divided into two: the low SYNTAX score group (≤22) and patients with a low SYNTAX score (≤22) and medium-high SYNTAX score (≥23). Bivariate analysis was performed to find the relationship between the TG/HDL ratio and the SYNTAX score. The value of p<0.05 was considered statistically significant.
Results: From 53 patients, 26 patients (49.1%) had a SYNTAX score ≥ 23 and 27 patients (50.9%) had a SYNTAX score < 23. Patients with NSTEMI, DM risk factors, and obesity were higher in the SYNTAX score group ≥23. From the results of statistical analysis, there was a significant relationship between the TG/HDL ratio with coronary lesion severity (p = 0,004).
Conclusion : Enhancement of TG/HDL ratio is correlated with coronary lesion severity in acute myocardial infarction patients using the SYNTAX score.
Keywords: TG/HDL Ratio, Coronary Lesion Severity, SYNTAX Score
- Juzar DA. Pedoman Tatalaksana Sindrom Koroner Akut. Edisi-4. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. 2018 : 1-4PubMedGoogle Scholar
- Rhee JW, Sabatine MS, Lilly LS. Acute coronary syndrome. In: Lilly LS (ed.) Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty, 5th edition. Baltimore: Lippincott of Williams and Wilkin. 2015 ; 166-176PubMedGoogle Scholar
- Yuksel M, Yildiz A, Oylumlu M. The Association between Platelet/ Lymphocyte Ratio and Coronary Artery Disease Severity. Anatol J Cardiol 2015; 15:640PubMedGoogle Scholar
- Serruys PW, Onuma Y, Garg S. Assessment of the SYNTAX Score in the Syntax Study. EuroIntervention 2009. 5(1): 50–56.PubMedGoogle Scholar
- Sianos G, Morel MA, Kappetein AP. The SYNTAX score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005 (1): 219-27PubMedGoogle Scholar
- Ugur K and Recep K. Association of the TG/HDL-C and Monocyte Count/HDL-C Ratios with Coronary Artery Disease in Non-ST Segment Elevation Myocardial Infarction. Medical Laboratory Technology Journal. 2019 ; 5 (1) : 6-7.PubMedGoogle Scholar
- Gharipour M, Sadeghi M, Dianatkhah M, Nezafati P, Talaie M, Oveisgharan S. Comparison between European and Iranian Cut-off Points of Triglyceride / High-Density Lipoprotein Cholesterol Concentrations in Predicting Cardiovascular Disease Outcomes, Journal of Clinical Lipidology. 2015: 3-10PubMedGoogle Scholar
- Hajian-Tilaki K, Heidari B, Bakhtiari A. Triglyceride to High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratios are Predictors of Cardiovascular Risk in Iranian Adults: Evidence from a population-based cross-sectional study. Caspian J Intern Med. 2020; 11(1):53-61.PubMedGoogle Scholar
- Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pagoda JM, Labree L. et al. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation.2011; 90:42-49.PubMedGoogle Scholar
- Hunninghake DB, Stein EA, Bays HE. Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia. Coronary Artery Disease. 2004, 15:115–123.PubMedGoogle Scholar
- Mach F, Catapano A, Koskinas K, et al. 2019. ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modificationPubMedGoogle Scholar